
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.350047 | -4.23273276904 | 8.27 | 8.8789 | 7.54 | 10732 | 8.05086076 | CS |
4 | -2.140047 | -21.272833002 | 10.06 | 12 | 7.54 | 11403 | 9.24946938 | CS |
12 | 2.193953 | 38.3156304576 | 5.726 | 13.79 | 4.5601 | 125686 | 8.73006623 | CS |
26 | 0.319953 | 4.20990789474 | 7.6 | 13.79 | 4.5601 | 76998 | 8.2403873 | CS |
52 | -1.650047 | -17.2418704284 | 9.57 | 19 | 4.5601 | 99928 | 9.65174242 | CS |
156 | -18.580047 | -70.1133849057 | 26.5 | 43.2 | 4.5601 | 110261 | 19.84554337 | CS |
260 | -112.480047 | -93.4219659468 | 120.4 | 221.55 | 4.5601 | 108266 | 25.95386721 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales